Scotiabank analyst Nicholas Yulico raised the firm’s price target on American Healthcare REIT (AHR) to $55 from $47 and keeps an Outperform rating on the shares. The firm is updating its price targets for U.S. Real Estate & REITs stocks under its coverage, the analyst tells investors. The company remains one of its top picks for exposure to the segment.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $55 from $43 at KeyBanc
- American Healthcare REIT price target raised to $54 from $45 at RBC Capital
- American Healthcare REIT price target raised to $60 from $50 at Citizens JMP
- American Healthcare REIT Reports Robust Earnings Growth
- American Healthcare REIT, Inc. Reports Strong Q3 2025 Results